Evolution of Plasmodium vivax and resistance patterns for infection based on Duffy genotype and phenotype
- PMID: 37701383
- PMCID: PMC10495050
- DOI: 10.53854/liim-3103-8
Evolution of Plasmodium vivax and resistance patterns for infection based on Duffy genotype and phenotype
Abstract
The Duffy protein, a transmembrane molecule, acts as a receptor for various chemokines and facilitates binding between reticulocytes and the Plasmodium Duffy antigen binding protein. Duffy expression is associated with the Duffy chemokine receptor antigen genotype on chromosome 1 and exhibits variation across different geographic regions. Traditionally, the Duffy negative genotype and phenotype have been described to confer a certain level of protection against infection and symptom development. However, recent data suggest a shift in this behavior, with significantly higher prevalence observed in individuals with Duffy negative genotype or phenotype. Given that malaria is an endemic vector-borne disease in regions of Asia, Africa, and Latin America, posing a substantial global burden of disease and prioritizing public and global health, identifying evolutionary changes in infection and resistance patterns holds great importance for the design of strategies and reevaluation of conventional interventions. Hence, the aim of this review was to analyze the evolution of Plasmodium vivax and infection resistance patterns based on Duffy genotype and phenotype. The distribution of genotypes, phenotypes, and polymorphisms of P. vivax ligands and erythrocyte receptors varies geographically, notably resistance patterns of this microorganism in individuals with Duffy negative genotype and phenotype have significantly changed compared to studies conducted 30 years ago. The prevalence of vivax malaria in individuals with a Duffy negative status can reach up to 100%. Consequently, prioritizing research on this topic is essential for public health.
Keywords: Plasmodium; Plasmodium vivax; disease resistance; duffy blood-group system; malaria.
Conflict of interest statement
Conflicts of interest The authors declare no conflict of interest in regard to this work.
Figures


Similar articles
-
Relationship between Duffy Genotype/Phenotype and Prevalence of Plasmodium vivax Infection: A Systematic Review.Trop Med Infect Dis. 2023 Sep 30;8(10):463. doi: 10.3390/tropicalmed8100463. Trop Med Infect Dis. 2023. PMID: 37888591 Free PMC article. Review.
-
The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health.Malar J. 2020 Aug 24;19(1):299. doi: 10.1186/s12936-020-03372-9. Malar J. 2020. PMID: 32831093 Free PMC article. Review.
-
High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana.Malar J. 2021 Feb 17;20(1):99. doi: 10.1186/s12936-021-03618-0. Malar J. 2021. PMID: 33596926 Free PMC article.
-
Detection of Duffy Blood Group Genotypes and Submicroscopic Plasmodium Infections Using Molecular Diagnostic Assays in Febrile Malaria Patients.Res Sq [Preprint]. 2023 Dec 6:rs.3.rs-3706814. doi: 10.21203/rs.3.rs-3706814/v1. Res Sq. 2023. Update in: Malar J. 2024 Jun 20;23(1):194. doi: 10.1186/s12936-024-04875-5. PMID: 38105972 Free PMC article. Updated. Preprint.
-
Presence of additional Plasmodium vivax malaria in Duffy negative individuals from Southwestern Nigeria.Malar J. 2020 Jun 26;19(1):229. doi: 10.1186/s12936-020-03301-w. Malar J. 2020. PMID: 32590997 Free PMC article.
References
-
- Douglas NM, Burkot TR, Price RN. Malaria eradication revisited. Int J Epidemiol. 2022;51(2):382–392. - PubMed
-
- World Health Organization. WHO Guidelines for malaria [Internet] [Consulted 04 Jun 2023]. Available in: https://www.who.int/publications/i/item/guidelines-for-malaria.
-
- Centers for Disease Control and Prevention. Malaria [Internet] [Consulted 04 Jun 2023]. Available in: https://www.cdc.gov/parasites/malaria/index.html.
Publication types
LinkOut - more resources
Full Text Sources